Optogenetic inhibition of ventral hippocampal neurons alleviates associative motor learning dysfunction in a rodent model of schizophrenia

Autoři: Zheng-li Fan aff001;  Bing Wu aff001;  Guang-yan Wu aff001;  Juan Yao aff001;  Xuan Li aff001;  Ke-hui Hu aff003;  Zhen-hua Zhou aff004;  Jian-feng Sui aff001
Působiště autorů: Department of Physiology, College of Basic Medical Science, Army Medical University, Chongqing, P.R. China aff001;  Experimental Center of Basic Medicine, College of Basic Medical Science, Army Medical University, Chongqing, P.R. China aff002;  Department of Rehabilitation, Suining Central Hospital, Suining, P.R. China aff003;  Department of Neurology, First Affiliated Hospital of Army Medical University, Chongqing, P.R. China aff004
Vyšlo v časopise: PLoS ONE 14(12)
Kategorie: Research Article
doi: 10.1371/journal.pone.0227200


Schizophrenia (SZ) is a serious and incurable mental disorder characterized by clinical manifestations of positive and negative symptoms and cognitive dysfunction. High-frequency deep brain stimulation (DBS) of the ventral hippocampus (VHP) has been recently applied as a therapeutic approach for SZ in both experimental and clinical studies. However, little is known about the precise mechanism of VHP-DBS treatment for SZ and the role of hippocampal cell activation in the pathogenesis of SZ. With optogenetic technology in this study, we tried to inhibit neuronal activity in the VHP which has dense projections to the prefrontal cortex, before measuring long stumulus-induced delay eyeblink conditioning (long-dEBC) in a rodent model of SZ. Rats were administrated with phencyclidine (PCP, 3 mg/kg, 1/d, ip) for successive 7 days before optogenetic intervention. The current data show that PCP administration causes significant impairment in the acquisition and timing of long-dEBC; the inhibition of bilateral VHP neurons alleviates the decreased acquisition and impaired timing of longd-dEBC in PCP-administered rats. The results provide direct evidence at the cellular level that the inhibition of VHP neuronal cells may be a prominent effect of hippocampal DBS intervention, and increased activity in the hippocampal network play a pivotal role in SZ.

Klíčová slova:

Cognitive impairment – Electromyography – Fiber optics – Hippocampus – Neurons – Optogenetics – Rats – Deep-brain stimulation


1. Llado-Pelfort L, Troyano-Rodriguez E, van den Munkhof HE, Cervera-Ferri A, Jurado N, et al. Phencyclidine-induced disruption of oscillatory activity in prefrontal cortex: Effects of antipsychotic drugs and receptor ligands. Eur Neuropsychopharmacol. 2016; 26(3):614–25. doi: 10.1016/j.euroneuro.2015.11.015 26781158

2. Ewing SG, Grace AA. Deep brain stimulation of the ventral hippocampus restores deficits in processing of auditory evoked potentials in a rodent developmental disruption model of schizophrenia. Schizophr Res. 2013; 143(2–3):377–83. doi: 10.1016/j.schres.2012.11.023 23269227

3. Poortvliet PC, Silburn PA, Coyne TJ, Chenery HJ. Deep brain stimulation for Parkinson disease in Australia: current scientific and clinical status. Intern Med J. 2015; 45(2):134–9. doi: 10.1111/imj.12656 25650534

4. Lakhan SE, Callaway E. Deep brain stimulation for obsessive-compulsive disorder and treatment-resistant depression: systematic review. BMC Res Notes. 2010; 3:60. doi: 10.1186/1756-0500-3-60 20202203

5. Breit S, Schulz JB, Benabid AL. Deep brain stimulation. Cell Tissue Res. 2004; 318(1):275–88. doi: 10.1007/s00441-004-0936-0 15322914

6. Benabid AL, Benazzous A, Pollak P. Mechanisms of deep brain stimulation. Mov Disord. 2002; 17 Suppl 3:S73–4.

7. Perez SM, Shah A, Asher A, Lodge DJ. Hippocampal deep brain stimulation reverses physiological and behavioural deficits in a rodent model of schizophrenia. Int J Neuropsychopharmacol. 2013; 16(6):1331–9. doi: 10.1017/S1461145712001344 23190686

8. Corripio I, Sarro S, McKenna PJ, Molet J, Alvarez E, et al. Clinical Improvement in a Treatment-Resistant Patient With Schizophrenia Treated With Deep Brain Stimulation. Biol Psychiatry. 2016; 80(8):e69–70. doi: 10.1016/j.biopsych.2016.03.1049 27113497

9. Bikovsky L, Hadar R, Soto-Montenegro ML, Klein J, Weiner I, et al. Deep brain stimulation improves behavior and modulates neural circuits in a rodent model of schizophrenia. Exp Neurol. 2016; 283(Pt A):142–50. doi: 10.1016/j.expneurol.2016.06.012 27302677

10. Ma J, Leung LS. Deep brain stimulation of the medial septum or nucleus accumbens alleviates psychosis-relevant behavior in ketamine-treated rats. Behav Brain Res. 2014; 266:174–82. doi: 10.1016/j.bbr.2014.03.010 24632470

11. Graat I, Figee M, Denys D. The application of deep brain stimulation in the treatment of psychiatric disorders. Int Rev Psychiatry. 2017; 29(2):178–90. doi: 10.1080/09540261.2017.1282439 28523977

12. Deisseroth K. Optogenetics. Nat Methods. 2011; 8(1):26–9. doi: 10.1038/nmeth.f.324 21191368

13. Gradinaru V, Mogri M, Thompson KR, Henderson JM, Deisseroth K. Optical deconstruction of parkinsonian neural circuitry. Science. 2009; 324(5925):354–9. doi: 10.1126/science.1167093 19299587

14. Ewing SG, Winter C. The ventral portion of the CA1 region of the hippocampus and the prefrontal cortex as candidate regions for neuromodulation in schizophrenia. Med Hypotheses. 2013; 80(6):827–32. doi: 10.1016/j.mehy.2013.03.026 23583328

15. Morris BJ, Cochran SM, Pratt JA. PCP: from pharmacology to modelling schizophrenia. Curr Opin Pharmacol. 2005; 5(1):101–6. doi: 10.1016/j.coph.2004.08.008 15661633

16. Jodo E. The role of the hippocampo-prefrontal cortex system in phencyclidine-induced psychosis: a model for schizophrenia. J Physiol Paris. 2013; 107(6):434–40. doi: 10.1016/j.jphysparis.2013.06.002 23792022

17. Jodo E, Suzuki Y, Takeuchi S, Niwa S, Kayama Y. Different effects of phencyclidine and methamphetamine on firing activity of medial prefrontal cortex neurons in freely moving rats. Brain Res. 2003; 962(1–2):226–31. doi: 10.1016/s0006-8993(02)03967-7 12543474

18. Takahata R, Moghaddam B. Activation of glutamate neurotransmission in the prefrontal cortex sustains the motoric and dopaminergic effects of phencyclidine. Neuropsychopharmacology. 2003; 28(6):1117–24. doi: 10.1038/sj.npp.1300127 12700703

19. Kalmbach BE, Ohyama T, Mauk MD. Temporal patterns of inputs to cerebellum necessary and sufficient for trace eyelid conditioning. J Neurophysiol. 2010; 104(2):627–40. doi: 10.1152/jn.00169.2010 20484534

20. Jessen F, Scheef L, Germeshausen L, Tawo Y, Kockler M, et al. Reduced hippocampal activation during encoding and recognition of words in schizophrenia patients. Am J Psychiatry. 2003; 160(7):1305–12. doi: 10.1176/appi.ajp.160.7.1305 12832246

21. Kim JJ, Thompson RF. Cerebellar circuits and synaptic mechanisms involved in classical eyeblink conditioning. Trends Neurosci. 1997; 20(4):177–81. doi: 10.1016/s0166-2236(96)10081-3 9106359

22. Tracy JA, Britton GB, Steinmetz JE. Comparison of single unit responses to tone, light, and compound conditioned stimuli during rabbit classical eyeblink conditioning. Neurobiol Learn Mem. 2001; 76(3):253–67. doi: 10.1006/nlme.2001.4024 11726236

23. Thompson RF. In search of memory traces. Annu Rev Psychol. 2005; 56:1–23. doi: 10.1146/annurev.psych.56.091103.070239 15709927

24. Beylin AV, Gandhi CC, Wood GE, Talk AC, Matzel LD, et al. The role of the hippocampus in trace conditioning: temporal discontinuity or task difficulty? Neurobiol Learn Mem. 2001; 76(3):447–61. doi: 10.1006/nlme.2001.4039 11726247

25. Wu GY, Yao J, Hu B, Zhang HM, Li YD, et al. Reevaluating the role of the hippocampus in delay eyeblink conditioning. PLoS One. 2013; 8(8):e71249. doi: 10.1371/journal.pone.0071249 23951119

26. Reeb-Sutherland BC, Fox NA. Eyeblink conditioning: a non-invasive biomarker for neurodevelopmental disorders. J Autism Dev Disord. 2015; 45(2):376–94. doi: 10.1007/s10803-013-1905-9 23942847

27. Firth J, Stubbs B, Rosenbaum S, Vancampfort D, Malchow B, et al. Aerobic Exercise Improves Cognitive Functioning in People With Schizophrenia: A Systematic Review and Meta-Analysis. Schizophr Bull. 2017 43(3):546–56. doi: 10.1093/schbul/sbw115 27521348

28. Harvey PD. Pharmacological cognitive enhancement in schizophrenia. Neuropsychol Rev. 2009; 19(3):324–35. doi: 10.1007/s11065-009-9103-4 19507034

29. Green MF, Kern RS, Braff DL, Mintz J. Neurocognitive deficits and functional outcome in schizophrenia: are we measuring the "right stuff"? Schizophr Bull. 2000; 26(1):119–36. doi: 10.1093/oxfordjournals.schbul.a033430 10755673

30. Wu GY, Liu SL, Yao J, Li X, Wu B, et al. Optogenetic Inhibition of Medial Prefrontal Cortex-Pontine Nuclei Projections During the Stimulus-free Trace Interval Impairs Temporal Associative Motor Learning. Cereb Cortex. 2018; 28(11):3753–63. doi: 10.1093/cercor/bhx238 28968654

31. Kent JS, Bolbecker AR, O'Donnell BF, Hetrick WP. Eyeblink Conditioning in Schizophrenia: A Critical Review. Front Psychiatry. 2015; 6:146. doi: 10.3389/fpsyt.2015.00146 26733890

32. Forsyth JK, Bolbecker AR, Mehta CS, Klaunig MJ, Steinmetz JE, et al. Cerebellar-dependent eyeblink conditioning deficits in schizophrenia spectrum disorders. Schizophr Bull. 2012; 38(4):751–9. doi: 10.1093/schbul/sbq148 21148238

33. Sears LL, Andreasen NC, O'Leary DS. Cerebellar functional abnormalities in schizophrenia are suggested by classical eyeblink conditioning. Biol Psychiatry. 2000; 48(3):204–9. doi: 10.1016/s0006-3223(00)00247-x 10924663

34. Bolton MM, Heaney CF, Sabbagh JJ, Murtishaw AS, Magcalas CM, et al. Deficits in emotional learning and memory in an animal model of schizophrenia. Behav Brain Res. 2012; 233(1):35–44. doi: 10.1016/j.bbr.2012.04.049 22569573

35. Marenco S, Weinberger DR, Schreurs BG. Single-cue delay and trace classical conditioning in schizophrenia. Biol Psychiatry. 2003; 53(5):390–402. doi: 10.1016/s0006-3223(02)01506-8 12614992

36. Heckers S, Rauch SL, Goff D, Savage CR, Schacter DL, et al. Impaired recruitment of the hippocampus during conscious recollection in schizophrenia. Nat Neurosci. 1998; 1(4):318–23. doi: 10.1038/1137 10195166

37. Suddath RL, Christison GW, Torrey EF, Casanova MF, Weinberger DR. Anatomical abnormalities in the brains of monozygotic twins discordant for schizophrenia. N Engl J Med. 1990; 322(12):789–94. doi: 10.1056/NEJM199003223221201 2308615

38. Weinberger DR. Cell biology of the hippocampal formation in schizophrenia. Biol Psychiatry. 1999; 45(4):395–402. doi: 10.1016/s0006-3223(98)00331-x 10071707

39. Wu B, Zhao XD, Zhang HM, Li X, Wu GY, Yang YS, Tian CY, Sui JF, et al. Prolonged deficits of associative motor learning in cynomolgus monkeys after long-term administration of phencyclidine. Behav Brain Res. 2017; 331(7):169–176.

40. Kravitz AV, Freeze BS, Parker PR, Kay K, Thwin MT, et al. Regulation of parkinsonian motor behaviours by optogenetic control of basal ganglia circuitry. Nature. 2010; 466(7306):622–6. doi: 10.1038/nature09159 20613723

41. Kravitz AV, Tye LD, Kreitzer AC. Distinct roles for direct and indirect pathway striatal neurons in reinforcement. Nat Neurosci. 2012; 15(6):816–8. doi: 10.1038/nn.3100 22544310

42. Gee S, Ellwood I, Patel T, Luongo F, Deisseroth K, et al. Synaptic activity unmasks dopamine D2 receptor modulation of a specific class of layer V pyramidal neurons in prefrontal cortex. J Neurosci. 2012; 32(14):4959–71. doi: 10.1523/JNEUROSCI.5835-11.2012 22492051

43. Peled A. Optogenetic neuronal control in schizophrenia. Med Hypotheses. 2011; 76(6):914–21. doi: 10.1016/j.mehy.2011.03.009 21482453

Článek vyšel v časopise


2019 Číslo 12